Cytori Gains as Much as 21% After Contract Award

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Sept. 28 (Bloomberg) -- Cytori Therapeutics, a biotechnology company with $10 million in annual revenue, rose the most in more than a year after the company won a $4.7 million U.S. government contract to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs. Alix Steel reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change